dr. shahda on bbi-608 with gemcitabine and nab-paclitaxel in patients with mpdac
Published 8 years ago • 320 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:02
dr. safi shahda on a phase ib study investigating bbi-608 for mpdac
-
2:01
dr. saab on napabucasin with gemcitabine and nab-paclitaxel in pancreatic adenocarcinoma
-
3:26
promising results for napabucasin plus nab-paclitaxel with gemcitabine in pancreatic cancer
-
0:58
dr. saab on napabucasin (bbi-608) in colorectal cancer treatment
-
1:30
dr. bekaii-saab on napabucasin plus nab-paclitaxel in pancreatic cancer
-
4:05
schedules for gemcitabine, nab-paclitaxel for pancreatic cancer
-
1:22
dr. ramesh ramanathan on nab-paclitaxel plus gemcitabine in pancreatic cancer
-
1:11
dr. ramanathan on gemcitabine/nab-paclitaxel followed by mfolfirinox in pancreatic cancer
-
2:45
sequence: nab-paclitaxel/gemcitabine with modified folfox in pancreatic cancer
-
3:55
brighter trial underway to assess bbi-608 for advanced, metastatic gastric cancers
-
2:06
a study of nivolumab with nab-paclitaxel plus gemcitabine in pancreatic cancer
-
0:43
danis-2: nis793 with nab-paclitaxel and gemcitabine in mpdac
-
2:25
tarextumab in combination with nab-paclitaxel and gemcitabine in pancreatic cancer
-
9:47
nab-paclitaxel plus gemcitabine in advanced pancreatic cancer
-
1:38
dr. bekaii-saab on napabucasin in patients with pancreatic cancer
-
1:24
pegph20 with nab-paclitaxel/gemcitabine in pancreatic cancer
-
1:42
dr. bekaii-saab on the apact trial in pancreatic cancer
-
1:16
dr. o'reilly on nab-paclitaxel plus gemcitabine vs folfirinox
-
2:28
bbi608, weekly paclitaxel in advanced gastric cancer